• Shuffle
    Toggle On
    Toggle Off
  • Alphabetize
    Toggle On
    Toggle Off
  • Front First
    Toggle On
    Toggle Off
  • Both Sides
    Toggle On
    Toggle Off
  • Read
    Toggle On
    Toggle Off
Reading...
Front

Card Range To Study

through

image

Play button

image

Play button

image

Progress

1/124

Click to flip

Use LEFT and RIGHT arrow keys to navigate between flashcards;

Use UP and DOWN arrow keys to flip the card;

H to show hint;

A reads text to speech;

124 Cards in this Set

  • Front
  • Back
Factors that affect hormone binding protein synthesis
Estrogen increases binding proteins; androgens decrease binding proteins. In pregnancy there's increased total hormones with normal levels of free hormone.
Site of synthesis of CRH
Paraventricular nucleus
Site of synthesis of TRH
Paraventricular nucleus
Site of synthesis of PIF
Arcuate nucleus
Site of synthesis of GHRH
Arcuate nucleus
Site of synthesis of GnRH
Preoptic region
Site of synthesis of ADH
Supraoptic and paraventricular nuclei
How do hypothalamic hormones reach the anterior pituitary?
Hormones are released in the hypophyseal-portal system
Hypothalamic hormones
GHRH, GnRH, PIF (dopamine), TRH, CRH, Somatostatin, ADH, prolactin
Anterior pituitary hormones
ACTH, TSH, LH, FSH, GH, prolactin
Sheehan syndrome
Ischemic necrosis of the pituitary due to severe blood loss during delivery. Causes hypopituitarism.
Obstruction of pituitary stalk
Adenoma compresses pituitary stalk and decreases secretion of anterior pituitary hormones except prolactin.
What prevents downregulation of pituitary receptors?
Pulsatile release of hypothalamic hormones.
Hyperprolactinemia
Results from dopamine antagonists or pituitary adenomas that compress the pituitary stalk. Amenorrhea, galactorrhea, decreased libido, impotence, hypogonadism
What hormone controls release of cortisol and adrenal androgens?
ACTH
What hormone regulates release of aldosterone?
Angiotensin II and also potassium in hyperkalemia
Layers of the adrenal cortex
From external to internal: glomerulosa (aldosterone), fasciculata (cortisol), reticularis (androgens)
Consequences of loss of zona glomerulosa
No aldosterone: loss of Na, ↓ECF, ↓blood pressure, circulatory shock, death
Consequences of loss of zona fasciculata
No cortisol: circulatory failure (cortisol is permissive for cathecolamine vasoconstriction), can't mobilize energy stores during exercise or cold (hypoglycemia)
Consequences of loss of adrenal medulla
No epinephrine: decreased capacity to mobilize fat and glycogen during stress. Not necessary for survival.
What are the 17-OH steroids?
17OHpregnenolone, 17OHprogesterone, 11-deoxycortisol, cortisol. Urinary 17OH steroids are an index of cortisol secretion.
What is the rate-limiting enzyme for steroid hormone synthesis?
Desmolase - converts cholesterol into pregnenolone
What are the 17-ketosteroids?
DHEA and androstenidione
DHEA
Weak androgen 17-ketosteroid conjugated with sulfateto make it water-soluble
What is measured as an index of androgen production?
Urinary 17-ketosteroids. In females and prepubertal males is an index of adrenal 17-ketosteroids. In postpubertal males is an index of 2/3 adrenal androgens and 1/3 testicular androgens.
Stimulus for the zona glomerulosa
Angiotensin II and potassium in hyperkalemia stimulate production of aldosterone
Hormone responsible for negative feedback for ACTH release
Cortisol
Enzyme deficiencies that produce congenital adrenal hyperplasia and low cortisol levels
21β-OH, 11β-OH and 17α-OH all result in low cortisol levels.
21β-OH deficiency
No aldosterone: loss of Na, ↓ECF, ↓blood pressure in spite of high renin and angiotensin II, circulatory shock, death. No cortisol (low 17OH steroids): skin hyperpigmentation (due to excess ACTH), adrenal hyperplasia, hypotension (persmissive for catecholamines), fasting hypoglycemia. Excess androgens (17-ketosteroids): female pseudohermaphrodite, hirsutism
11β-OH deficiency
Excess 11-deoxycorticosterone: Na and water retention, low-renin hypertension. No cortisol (low 17OH steroids): skin hyperpigmentation (due to excess ACTH), adrenal hyperplasia, fasting hypoglycemia. Excess androgens (17-ketosteroids): female pseudohermaphrodite, hirsutism
17α-OH deficiency
Excess 11-deoxycorticosterone and low aldosterone (no AII): Na and water retention, low-renin hypertension. No cortisol: skin hyperpigmentation (due to excess ACTH), adrenal hyperplasia; corticosterone partially compensates low cortisol levels. No 17-ketosteroids: male pseudohermaphrodite, no testosterone, no estrogen.
↓17OH-steroids ↑ACTH, ↓blood pressure, ↓mineralocorticoids, ↑17-ketosteroids
21β-OH deficiency
↓17OH-steroids ↑ACTH, ↑blood pressure, ↓aldosterone, ↑11-deoxycorticosterone, ↑17-ketosteroids
11β-OH deficiency
↓17OH-steroids ↑ACTH, ↑blood pressure, ↓aldosterone, ↑11-deoxycorticosterone, ↓17-ketosteroids
17α-OH deficiency
Stress hormones
GH, Glucagon, cortisol, epinephrine
Actions of GH in stress situations
Mobilizes fatty acids by increasing lipolysis in adipose tissue
Actions of glucagon in stress situations
Mobilizes glucose by increasing liver glycogenolysis
Actions of cortisol in stress situations
Mobilizes fat, carbs and proteins
Actions of epinephrine in stress
Mobilizes glucose via glycogenolysis and fat via lipolysis.
Metabolic actions of cortisol
1) Protein catabolism and delivery of amino acids; 2) lipolysis and delivery of fatty acids and glycerol 3) gluconeogenesis raises glycemia; also inhibits glucose uptake.
Permissive actions of cortisol
Enhances glucagon (without cortisol --> fasting hypoglycemia); enhances epinephrine (without cortisol -->hypotension)
α-MSH
Stimulates melanocytes and causes darkening of skin. Synthesized along with ACTH from pro-opiomelanocortin.
↑cortisol, ↓CRH, ↓ACTH, no hyperpigmentation
Primary hypercortisolism
↓cortisol, ↑CRH, ↑ACTH, hyperpigmentation
Addison disease - primary hypocortisolism
↑cortisol, ↓CRH, ↑ACTH, hyperpigmentation
Secondary hypercortisolism
↓cortisol, ↑CRH, ↓ACTH, no hyperpigmentation
Secondary hypocortisolism
↓cortisol, ↓CRH, ↓ACTH, no hyperpigmentation, symptoms of excess cortisol
Steroid administration
Cushing syndrome
Protein depletion, weak inflammatory response, poor wound healing, hyperglycemia, hyperinsulinemia, insulin resistance, hyperlipidemia, osteoporosis, purple striae, hirsutism, hypertension, hypokalemic alkalosis, buffalo hump
Actions of aldosterone
↑Na channels in lumen of principal cells, ↑activity of Na/K ATPase of principal cells --> increases Na reabsorption. Also ↑ secretion of K and H leading to hypokalemic metabolic alkalosis.
Addison disease
↑ ACTH, hyperpigmentation, hypotension (no aldosterone, no cortisol), hyperkalemic metabolic acidosis (no aldosterone), loss of body hair (no androgens), hypoglycemia, ↑ ADH secretion
Causes of secondary hyperaldosteronism
CHF, vena cava constriction, cirrhosis, renal artery stenosis
Primary hyperaldosteronism
Na and water retention, hypertension, hypokalemic metabolic alkalosis, ↓ renin and angiotensin, no edema due to pressure diuresis and natriuresis.
Primary hypoaldosteronism
Na and water loss, hypotension, hyperkalemic metabolic acidosis, ↑ renin and angiotensin II, no edema
Secondary hyperaldosteronism
↑ renin and angiotensin II, ↑ Na and water retention in venous circulation, edema
Factors that influence ADH secretion
↑ osmolarity --> ↑ ADH secretion; ↓ blood volume --> baroreceptors --> medulla --> ↑ ADH secretion
Actions of ADH
Inserts water channels in luminal membrane of collecting ducts, increases reabsorption of water.
Central diabetes insipidus
Not enough ADH secreted. Dilute urine is formed in spite of water deprivation. Responds to injected ADH.
Nephrogenic diabetes insipidus
ADH is secreted but ducts are unresponsive to it. Dilute urine is formed in spite of water deprivation or injected ADH.
SIADH
Excessive secretion of ADH in spite of low osmolarity. Concentrated urine is formed.
↓ permeability of collecting ducts, ↑ urine, ↓ urine osmolarity, ↓ ECF, ↑ osmolarity
Diabetes insipidus
↑ permeability of collecting ducts, ↓ urine, ↑ urine osmolarity, ↓ ECF, ↑ osmolarity
Dehydration
↑ permeability of collecting ducts, ↓ urine, ↑ urine osmolarity, ↑ ECF, ↓ osmolarity
SIADH
↓ permeability of collecting ducts, ↑ urine, ↓ urine osmolarity, ↑ ECF, ↓ osmolarity
Primary polydipsia
Actions of ANP
Atrial stretch or ↑ osmolarity --> ANP secretion --> dilation of afferent, constriction of efferent --> ↑ GFR --> natriuresis; also decreases permeability of collecting ducts to water.
Delta cells of the pancreas
Between alpha and beta cells, represent 5% of islets. Secrete somatostatin.
Alpha cells of the pancreas
Near the periphery of the islets, represent 20%. Secrete glucagon.
Beta cells of the pancreas
In the center of the islets, represent 60-75%. Secrete insulin and C peptide.
Insulin receptor
Has intrinsic tyrosine kinasae activity. Insulin receptor substrate binds tyrosine kinase, activates SH2 domain proteins: PI-3 kinase (translocation of GLUT-4), p21RAS.
Tissues that require insulin for glucose uptake
Resting skeletal muscle and adipose tissue
Tissues independent of insulin for glucose uptake
Brain, kidneys, intestinal mucosa, red blood cells, beta cells of the pancreas.
Anabolic hormones
Insulin, GH/IGF-1, androgens, T3/T4, IGF-1 (somatomedin C)
Effects of insulin on potassium
Increases Na/K ATPase uptake of K. Insulin + glucose used to treat hyperkalemia.
Mechanism of insulin release
Glucose enters β cells and is metabolized --> ↑ ATP --> closes K channels --> ↑ depolarization --> ↑ Ca influx --> exocytosis of insulin.
Factors that stimulate secretion of insulin
Glucose, arginine, GIP, glucagon
Factors that inhibit insulin release
Somatostatin, norepinephrine via α1 receptors
↑ glucose, ↑ insulin, ↑ C peptide
Type 2 diabetes
↑ glucose, ↓ insulin, ↓ C peptide
Type 1 diabetes
↓ glucose, ↑ insulin, ↑ C peptide
Insulinoma
↓ glucose, ↑ insulin, ↓ C peptide
Factitious hypoglycemia (insulin injection)
Actions of somatomedin C
Increases cartilage synthesis at epiphyseal plates (↑ bone length). Also ↑ lean body mass. Protein-bound and long half-life correlates with GH secretion. Also called IGF-1.
Secretion of GH
Pulsatile during non-REM sleep; more frequent in puberty due to increased androgens; requires thyroid hormones; decreases in the elderly.
Factors that stimulate GH secretion
Deep sleep, hypoglycemia, exercise, arginine, GHRH, low somatostatin
Factors that inhibit GH secretion
Negative feedback by GH on GHRH; positive feedback on somatostatin by IGF-1
Dwarfism
Due to GH insensitivity during prepuberty
Acromegaly
Due to excess GH in postpuberty. Enlargement of hands, feet and lower jaw, increased proteins, decreased fat, visceromegaly, cardiac insuficiency.
Composition of bone
Phosphate and calcium precipitate forming hydroxyapatite in osteoid matrix.
Actions of PTH
Rapid actions: increases Ca reabsorption in distal tubules and decreases phosphate reabsorption in proximal tubules, thus lowering blood phosphate and lowering solubility product which leads to bone resorption and raises plasma Ca. Slow actions: increases number and activity of osteoclasts (via osteoclast activating factor released by osteoblasts), increases activity of alpha-1 hydroxylase in the proximal tubules which increases active vitamin D and absorption of Ca and phosphate in the instetines.
Clinical features of primary hyperparathyroidism
↑ plasma Ca and ↓ plasma phosphate, phosphaturia, polyuria, calciuria (filtered load of Ca exceeds Tm), ↑ serum alkaline phosphatase, ↑ urinary hydroxyproline, muscle weakness, easy fatigability.
Clinical features of primary hypoparathyroidism
↓ plasma Ca and ↑ plasma phosphate, hypocalcemic tetany due to increased excitability of motor neurons.
↑ PTH, ↑ Ca, ↓ phosphate
Primary hyperparathyroidism. Causes: parathyroid adenoma (MEN I and II), ectopic PTH tumor (lung squamous CA)
↓ PTH, ↓ Ca, ↑ phosphate
Primary hypoparathyroidism. Cause: surgical removal of parathyroid.
↑ PTH, ↓ Ca, ↑ phosphate
Secondary hyperparathyroidism due to renal failure (no active vitamin D, decreased GFR)
↑ PTH, ↓ Ca, ↓ phosphate
Secondary hyperparathyroidism. Causes: deficiency of vitamin D due to bad diet or fat malabsorption.
↓ PTH, ↑ Ca, ↑ phosphate
Secondary hypoparathyroidism due to excess vitamin D.
Vitamin D synthesis
Dietary and skin cholecalciferol is hydroxylated by 25-hydroxylase in the liver and activated to 1,25 di-OH cholecalciferol by 1-alpha hydroxylase in the proximal tubules.
Actions of 1,25 di-OH cholecalciferol
Increases Ca binding proteins by intestinal cells which increases intestinal reabsorption of Ca and phosphate. Also increases reabsorption of Ca in the distal tubules. Increased serum Ca promotes bone deposition.
Osteomalacia
Underminerilized bone in adults due to vitamin D deficiency leads to bone deformation and fractures. Low calcium leads to secondary hyperparathyroidism.
Rickets
Underminerilized bone in children due to vitamin D deficiency leads to bone deformation and fractures. Low calcium leads to secondary hyperparathyroidism.
Excess vitamin D
Leads to bone reosprtion and demineralization
Synthesis of thyroid hormones
1) Iodine is actively transported into follicle cell; 2) thyroglobulin is synthesized in the RER, glycosylated in the SER and packaged in the GA; 3) Peroxidase is found in the luminal membrane and catalizes oxidation of I-, iodination of thyroglobulin and coupling to form MITs and DITs; 4) iodinated thyroglobulin is stored in the follicle lumen.
Structure of thyroid hormones
T4 has iodine attached to carbons 3 and 5 of both fenol rings; T3 has iodide attached to carbons 3 and 5 of the amino terminal fenol ring and the 3 prime carbon of the hydroxyl end fenol ring; reverse T3 has iodide in carbon 3 of the amino terminal fenol ring but not carbon 5.
Secretion of thyroid hormones
Iodinated thyroglobulin is endocytosed from the lumen of the follicles into lysosomes. Thyroglobulin is degraded into amino acids, T3, T4, DITs and MITs. T4 and T3 are secreted in a 20:1 ratio. DITs and MITs are deiodinated and iodine is recycled.
Transport of thyroid hormones
99% is bound to TBG, 1% is free. T4 has greater affinity for TBG and a half-life of 6 days. T3 has greater affinity for nuclear receptor and is the active form with a 1 day half-life. 50:1 T4/T3 ratio in periphery.
Activation and degradation of thyroid hormones
5' monodeiodinase activates T4 into T3. 5-monodeiodinase inactivates T4 into reverse T3.
Actions of thyroid hormones
↑ metabolic rate by ↑ Na/K ATPase except in brain, uterus and testes; essential for brain maturation and menstrual cycle; permissive for bone growth; permissive for GH synthesis and secretion; ↑ clearance of cholesterol; required for activation of carotene; ↑ intestinal glucose absorption; ↑ affinity and number of β1 receptros in the heart.
Effects of hypothyroidism in newborns
↓ dendritic branching and myelination lead to mental retardation.
Effects of hypothyroidism in juveniles
Cretinism results in ↓ bone growth and ossification --> dwarfism. Due to lack of permissive action on GH.
Control of thyroid hormone secretion
Circulating T4 is responsible for negative feedback of TSH by decreasing sensitivity to TRH. T4 is converted to T3 in the thyrotroph to induce negative feedback.
Effects of TSH
Rapid actions: ↑ iodide trapping, ↑ synthesis of thyroglobulin, ↑ reuptake of iodinated thyroglobulin, ↑ secretion of T4; late effects: ↑ blood flow to thyroid gland, ↑ hypertrophy of follicles and goiter.
↓ T4, ↑ TSH, ↑ TRH
Primary hypothyroidism; ↑ TSH is the more sensible index
↓ T4, ↓ TSH, ↑ TRH
Pituitary (secondary) hypothyroidism
↓ T4, ↓ TSH, ↓ TRH
Hypothalamic (tertiary) hypothyroidism
↑ T4, ↑ TSH, ↓ TRH
Pituitary (secondary) hyperthyroidism
↑ T4, ↓ TSH, ↓ TRH
Graves disease
Pathophysiology of iodine deficiency
Thyroid makes less T4 and more T3 so actions of T3 may be normal but low levels of T4 stimulate TSH secretion with development of goiter. Thus euthyroid with goiter.
Clinical features of hypothyroidism
↓ basal metabolic rate with cold intolerance, ↓ cognition, hyperlipidemia, nonpitting myxedema (mucopolysacchride accumulation around eyes retains water), physiologic jaundice (↑ carotene), hoarse voice, constipation, anemia, lethargy
Clinical features of hyperthyroidism
↑ metabolic rate with heat intolerance and sweating, ↑ apetite with weight loss, muscle weakness, tremor, irritability, tachycardia, exophthalmos.
Leydig cells
Stimulated by LH; produce testosterone for peripheral tissues and Sertoli cells. Testosterone provides negative feedback for LH secretion by pituitary.
Sertoli cells
Stimulated by FSH; produce inhibins (inhibits secretion of FSH), estradiol (testosterone is converted by aromatase), androgen binding proteins and growth factors for sperm. Responsible for development of sperm in males. Also MIH in male fetus.
↓ sex steroids, ↑ LH, ↑ FSH
Primary hypogonadism or postmenopause.
↓ sex steroids, ↓ LH, ↓ FSH
Pituitary hypogonadism or constant GnRH infusion (downregulates GnRH receptors of pituitary.
↑ sex steroids, ↓ LH, ↓ FSH
Anabolic steroid therapy. LH supression causes Leydig cell atrophy with decreased Leydig testosterone which suppresses spermatogenesis.
↑ sex steroids, ↑ LH, ↑ FSH
Pulsatile infusion of GnRH
Fetal development of male structures
LH --> Leydig cells --> testosterone --> Wolffian ducts (internal male structures: epididymis, vasa deferentia and seminal vesicles). Testosterone + 5-alpha reductase --> dihydrotestosterone --> urogenital sinus and external organs. MIH by Sertoli cells --> regression of Mullerian ducts and female structures.